Interest in having HPV vaccination among adolescent boys in England

Vaccine

Volumn 30, Issue 30, 2012, Pages 4505-4510

  Forster, Alice S ^a,b   Marlow, Laura A V ^a   Wardle, Jane ^a   Stephenson, Judith ^a   Waller, Jo ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Human males; Human papillomavirus; Immunisation; Social acceptance

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CHILD HEALTH CARE; DECISION MAKING; HEALTH BELIEF; HEALTH LITERACY; HUMAN; HUMAN PAPILLOMAVIRUS VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM; VACCINATION;

ADOLESCENT; DECISION MAKING; ENGLAND; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; VACCINATION;

EID: 84862002443     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.066     Document Type: Article

References (49)

1. Lehtinen M., Paavonen J., Wheeler C.M., Jaisamrarn U., Garland S.M., Castellsague X., et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncology 2012, 13(January (1)):89-99.
2. The Future I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010; 341(July): c3493, http://dx.doi.org/10.1136/bmj.c3493.
3. Read T.R., Hocking J.S., Chen M.Y., Donovan B., Bradshaw C.S., Fairley C.K. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sexually Transmitted Infections 2011, 87(December (7)):544-547.
4. Donovan B., Franklin N., Guy R., Grulich A.E., Regan D.G., Ali H., et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infectious Diseases 2011, 11(January (1)):39-44.
5. Brotherton J.M., Fridman M., May C.L., Chappell G., Saville A.M., Gertig D.M. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011 Jun 18, 377(9783):2085-2092.
6. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010, 127(December (12)):2893-2917.
7. Kim J.J., Goldie S.J. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ 2009, 339(October):b3884.
8. Giuliano A.R., Palefsky J.M., Goldstone S., Moreira E.D., Penny M.E., Aranda C., et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. New England Journal of Medicine 2011, 364(February (5)):401-411.
9. Hillman R.J., Giuliano A.R., Palefsky J.M., Goldstone S., Moreira E.D., Vardas E., et al. The immunogenicity of quadrivalent HPV (types 6/11/16/18) vaccine in males aged 16-26. Clinical and Vaccine Immunology 2012, (February (2)):261-267.
10. Palefsky J.M., Giuliano A.R., Goldstone S., Moreira E.D., Aranda C., Jessen H., et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. New England Journal of Medicine 2011, 365(October (17)):1576-1585.
11. Koulova A., Tsui J., Irwin K., Van Damme P., Biellik R., Aguado M.T. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008. Vaccine 2008, 26(51):6529-6541.
12. Centers for disease control. Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. 2011. Report no. 60(50).
13. Palefsky J.M. Human papillomavirus-related disease in men: not just a women's issue. Journal of Adolescent Health 2010, 46(April (4 Suppl. 1)):S12-S19.
14. Barroso L., Wilkin T. Human papillomavirus vaccination in males: the state of the science. Current Infectious Disease Reports 2011, 13(April (2)):175-181.
15. Pitts M.K., Fox C., Willis J., Anderson J. What do gay men know about human papillomavirus? Australian gay men's knowledge and experience of anal cancer screening and human papillomavirus. Sexually Transmitted Diseases 2007, 34(March (3)):170-173.
16. Pitts M., Smith A., Croy S., Lyons A., Ryall R., Garland S., et al. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination. Vaccine 2009, 27(22):2989-2993.
17. Reiter P.L.P., Brewer N.T.P., McRee A.L.M., Gilbert P.M., Smith J.S.P. Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sexually Transmitted Diseases 2010, 37(March (3)):197-203.
18. Simatherai D., Catriona C.S., Fairley C.K., Bush M., Heley S., Chen M.Y. What men who have sex with men think about the human papillomavirus vaccine. Sexually Transmitted Infections 2009, 85(January (2)):148-149.
19. Sanchez D.M., Pathela P., Niccolai L.M., Schillinger J.A. Knowledge of human papillomavirus and anal cancer among men who have sex with men attending a New York City sexually transmitted diseases clinic. International Journal of STD and AIDS 2012, 23(January (1)):41-43.
20. Dahlstrom L.A., Sundstrom K., Young C., Lundholm C., Sparen P., Tran T.N. Awareness and knowledge of human papillomavirus in the Swedish adult population. Journal of Adolescent Health 2012, 50(February (2)):204-206.
21. Marek E., Dergez T., Rebek-Nagy G., Kricskovics A., Kovacs K., Bozsa S., et al. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine 2011, 29(November (47)):8591-8598.
22. Blodt S., Holmberg C., Muller-Nordhorn J., Rieckmann N. Human papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany. European Journal of Public Health 2011, (December).
23. Mishra A., Graham J.E. Risk, choice and the "girl vaccine": Unpacking human papillomavirus (HPV) immunisation. Health, Risk & Society 2012, 14(January (1)):57-69.
24. Samkange-Zeeb F.N., Spallek L., Zeeb H. Awareness and knowledge of sexually transmitted diseases (STDs) among school-going adolescents in Europe: a systematic review of published literature. BMC Public Health 2011, 11:727.
25. Brewer N., Ng T., McRee A.L., Reiter P. Men's beliefs about HPV-related disease. Journal of Behavioral Medicine 2010, 33(August (4)):274-281.
26. Ferris D.G., Waller J.L., Miller J., Patel P., Price G.A., Jackson L., et al. Variables associated with human papillomavirus (HPV) vaccine acceptance by men. Journal of the American Board of Family Medicine 2009, 22(1):34-42.
27. Jones M., Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. Journal of American College Health 2008, 57(1):23-32.
28. Reiter P.L., Brewer N.T., Smith J.S. Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sexually Transmitted Infections 2010, 86(June (3)):241-246.
29. Zimet G.D., Rosenthal S.L. HPV vaccine and males: issues and challenges. Gynecologic Oncology 2010, 117(May (2)):S26-S31.
30. Liddon N., Hood J., Wynn B.A., Markowitz L.E. Acceptability of human papillomavirus vaccine for males: a review of the literature. Journal of Adolescent Health 2010, 46(February (2)):113-123.
31. Stupiansky N.W., Alexander A.B., Zimet G.D. Human papillomavirus vaccine and men: what are the obstacles and challenges?. Current Opinion in Infectious Diseases 2012, 25(February (1)):86-91.
32. Forster A.S., Marlow L.A.V., Wardle J., Stephenson J., Waller J. Understanding adolescents' intentions to have the HPV vaccine. Vaccine 2010, 28(February (7)):1673-1676.
33. Fleiss J.L. The measurement of inter-rater agreement. Statistical methods 1981, John Wiley, New York. J.L. Fleiss (Ed.).
34. Rosenstock I.M. Why people use health services. The Milbank Memorial Fund Quarterly 1966, 44(July (3)):94-127.
35. Rogers R.W. Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. Social psychophysiology 1983, 153-176. Guilford Press, New York. J.T. Cacioppo, R.E. Petty (Eds.).
36. Ogilvie G., Anderson M., Marra F., McNeil S., Pielak K., Dawaw M., et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLOS Medicine 2010, 7(May (5)):e1000270.
37. Reiter P.L., Brewer N.T., Gottlieb S.L., McRee A.L., Smith J.S. Parents' health beliefs and HPV vaccination of their adolescent daughters. Social Science & Medicine 2009, 69(August (3)):475-480.
38. Gerend M.A., Weibley E., Bland H. Parental response to human papillomavirus vaccine availability: Uptake and intentions. Journal of Adolescent Health 2009, 45(November (5)):528-531.
39. Salmon D.A., Moulton L.H., Omer S.B., deHart M.P., Stokley S., Halsey N.A. Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. Archives of Pediatrics and Adolescent Medicine 2005, 159(5):470-476.
40. Yeganeh N., Curtis D., Kuo A. Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates. Vaccine 2010, 28(June (25)):4186-4191.
41. Rosenthal S.L., Rupp R., Zimet G.D., Meza H.M., Loza M.L., Short M.B., et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. Journal of Adolescent Health 2008, 43(September (3)):239-245.
42. Wheldon C.W., Daley E.M., Buhi E.R., Nyitray A.G., Giuliano A.R. Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States. Vaccine 2011, 29(October (45)):8060-8065.
43. Liau A., Stupiansky N.W., Rosenthal S.L., Zimet G.D. Health beliefs and vaccine costs regarding human papillomavirus (HPV) vaccination among a U.S. national sample of adult women. Preventive Medicine 2012, 54(March (3-4)):277-279.
44. Wheeler R. Gillick or Fraser? A plea for consistency over competence in children. BMJ 2006, 332(April (7545)):975.
45. Brabin L., Roberts S.A., Kitchener H.C. A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. BioMed Central: Public Health 2007, 7:20.
46. Stretch R., McCann R., Roberts S., Elton P., Baxter D., Brabin L. A qualitative study to assess school nurses' views on vaccinating 12-13 year old school girls against human papillomavirus without parental consent. BMC Public Health 2009, 9(1):254.
47. Ogilvie G.S., Remple V.P., Marra F., McNeil S.A., Naus M., Pielak K., et al. Intention of parents to have male children vaccinated with the human papillomavirus vaccine. Sexually Transmitted Infections 2008, 84(August (4)):318-323.
48. Dahlstrom L.A., Tran T.N., Lundholm C., Young C., Sundstrom K., Sparen P. Attitudes to HPV vaccination among parents of children aged 12-15 years-a population-based survey in Sweden. International Journal of Cancer 2010, 126(January (2)):500-507.
49. Reiter P.L., McRee A.L., Kadis J.A., Brewer N.T. HPV vaccine and adolescent males. Vaccine 2011, 29(August (34)):5595-5602.